Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ICC International Cannabis Corp WLDCF

Healthcare Drug Manufacturers - Major
ICC International Cannabis Corp is a Canadian company which is engaged in planning, designing, building and operating cannabis production, processing, and distribution facilities worldwide. The company through its holdings is engaged in the pharmaceutical distribution, wholesale importation, research, and development, as well as working interests in industrial hemp licenses in Greece, licenses to cultivate, produce, distribute, store, and export Cannabis and Cannabis derivatives in Colombia, the


OTCPK:WLDCF - Post by User

ICC International Cannabis Corp > Bullish?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by HiGhRoLLeR420on Mar 21, 2018 7:15am
81 Views
Post# 27751527

RE:Bullish?

RE:Bullish?According to my research from Thomson Reuters, 12 mo. target is Low of $3.00, mean of $3.27 and a high of $3.56. This is according to 3 analysts... Fair value is $1.52.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities